Impact of HLA alleles and cytokine polymorphisms on inhibitors development in children with severe haemophilia A

Haemophilia

Volumn 19, Issue 5, 2013, Pages 706-710

  Pergantou, H ^a   Varela, I ^a   Moraloglou, O ^a   Economou, M ^b   Spanou, K ^a   Kapsimali, Z ^a   Constantinidou, N ^a   Platokouki, H ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cytokines polymorphisms; FVIII inhibitors; HLA alleles; Severe Haemophilia A

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING INHIBITOR; CYTOKINE; GAMMA INTERFERON; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; RECOMBINANT BLOOD CLOTTING FACTOR 8; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CHROMOSOME INVERSION; DISEASE SEVERITY; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; GREECE; HAPLOTYPE; HEMOPHILIA A; HOMOZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

CYTOKINES POLYMORPHISMS; FVIII INHIBITORS; HLA ALLELES; SEVERE HAEMOPHILIA A;

ADOLESCENT; ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOKINES; FACTOR VIII; FEMALE; GENE FREQUENCY; GENOTYPE; HEMOPHILIA A; HLA ANTIGENS; HUMANS; INFANT; ISOANTIBODIES; MALE; POLYMORPHISM, GENETIC;

EID: 84883049801     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12168     Document Type: Article

References (25)

1. Gouw SC, van den Berg HM. The multifactorial etiology of inhibitor development in haemophilia: genetics and environment. Semin Thromb Hemost 2009; 35: 723-34.
2. Paisley S, Wight J, Currie E, Knight C. The management of inhibitors in haemophilia A: introduction and systematic review of current practice. Haemophilia 2003; 9: 405-17.
3. Oldenburg J, Schröder J, Brackmann HH, Müller-Reible C, Schwaab R, Tuddenham E. Environmental and genetic factors influencing inhibitor development. Semin Hematol 2004; 1(Suppl. 1): 82-8.
4. Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 2002; 4(Suppl. 3): S265-72.
5. Pavlova A, Delev D, Lacroix-Desmazes S et al. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor a and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A. J Thromb Haemost 2009; 7: 2006-15
6. Hay CR, Ollier W, Pepper L et al. HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party. Thromb Haemost 1997; 77: 234-7.
7. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
8. Astermark J, Berntorp E, White GC, Kroner BL. The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in haemophilia patients. Haemophilia 2001; 7: 267-72.
9. Lozier JN, Rosenberg PN, Goedert JJ, Menashe I. A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A. Haemophilia 2011; 17: 641-9.
10. De Barros MF, Herrero JCM, Sell AM et al. Influence of class I and II HLA alleles on inhibitor development in severe haemophilia A patients from the South of Brazil. Haemophilia 2011; 18: 1-5.
11. Pinto P, Ghosh K, Shetty S. Immune regulatory gene polymorphisms as predisposing risk factors for the development of factor VIII inhibitors in Indian severe haemophilia A patients. Haemophilia 2012; 18: 1-4.
12. Chaves D, Belisario A, Castro G, Santoro M, Rodrigues C. Analysis of cytokine genes polymorphism as markers for inhibitor development in haemophilia A. Intern J Immunogen 2010; 37: 79-82.
13. Liu Q, Sommer SS. Subcycling -PCR for multiple long-distance amplification of regions with high and low GC content: Application to the inversion hotspot in the factor VIII gene. Biotechniques 1998; 25: 1022-8.
14. Ragni MV, Ojeifo O, Feng J et al. Hemophilia Inhibitor Study. Risk factors for inhibitor formation in haemophilia: a prevalent case-control study. Haemophilia 2009; 15: 1074-82.
15. Oldenburg J, Pavlova A. Genetic risk factors for inhibitors to factor VIII and IX. Haemophilia 2006; 12(Suppl. 6): 15-22.
16. Oldenburg J, El-Maari O, Schwaab R. Inhibitor development in correlation to factor VIII genotypes. Haemophilia 2002; 8(Suppl. 2): 23-9.
17. Eskdale J, Keijsers V, Huizinga T, Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) licus. Genes Immun 1999; 1: 151-5.
18. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotype in juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42: 1101-8.
19. Rosado S, Rua-Figueroa I, Vargas JA et al. Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands. International J Immunogen 2008; 35: 235-42.
20. Hajeer AH, Lazarus M, Turner D et al. IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 1998; 27: 142-5.
21. Wergeland S, Beiske A, Nyland H et al. IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosis. Eur J Neurol 2005; 12: 171-5.
22. Bafunno V, Santacroce R, Chetta M et al. Polymorphisms in genes involved autoimmune disease and the risk of FVIII inhibitor development in Italian patients with haemophilia A. Haemophilia 2010; 16: 469-73.
23. Goussetis E, Varela I, Peristeri I et al. Cytokine gene polymorpisms and graft-versus-host disease in children after matched sibling hematopoietic stem cell transplantation: a single -center experience. Cell Mol Immunol 2011; 8: 1-5.
24. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Inteleukin-10 and the interleukin 10 receptor. Annu Rev Immunol 2001; 19: 683-765.
25. Hedrich CM, Bream JH. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res 2010; 47: 185-206.